Triglycerides to HDL ratio: what it means for metabolic health and heart risk
The triglycerides to HDL ratio is one of the clearest markers of metabolic health most people have never heard of. Here is what it tells you, why it often says more than LDL alone, and what drives it in either direction.
If you have had a blood test and been told your cholesterol is "fine" or "a bit high," the conversation almost certainly centred on low-density lipoprotein (LDL). High LDL, concern. Low LDL, reassurance. That is how most of us were taught to read a lipid panel, and it misses the more useful marker sitting on the same page.
Two people can walk out with the same LDL number and have completely different internal environments. One has low triglycerides, a strong high-density lipoprotein (HDL), and stable fasting glucose. The other does not. Same number, different reality. This is where the triglycerides to HDL ratio becomes useful, not because it replaces LDL, but because it gives you a read on how the system is actually functioning.
What follows is how to calculate the ratio, what the numbers tend to mean, and why the triglycerides HDL ratio deserves attention alongside the markers most people fixate on.
How to calculate the triglycerides to HDL ratio
The calculation is straightforward. Divide your fasting triglycerides by your HDL cholesterol. Both numbers appear on a standard lipid panel.
If your results are in mg/dL, which is standard in the US, divide triglycerides directly by HDL. A fasting triglyceride reading of 80 with an HDL of 60 gives a ratio of 1.3. If your results are in mmol/L, which is used in Australia, the UK, and most other countries, the same formula applies but the thresholds are different. The two units scale differently for triglycerides and HDL, so a ratio of 2.0 in mg/dL corresponds to roughly 0.9 in mmol/L.
The test should be fasting. Triglycerides rise after eating, and a non-fasting sample will push the ratio higher than it actually is. A 10- to 12-hour fast before the blood draw is standard.
What counts as low, high, and worth a closer look
There is no universal ideal ratio. The numbers only make sense in the context of how you are eating and how your metabolism is functioning. That said, patterns emerge consistently enough to be useful as starting points.
In mg/dL, a ratio under 2.0 generally indicates that the body is handling energy well. Under 1.0 is what I consider a strong marker of metabolic health. Between 2.0 and 4.0 is worth a closer look, especially alongside fasting glucose and insulin. Above 4.0 usually means insulin resistance is present and the metabolic picture needs attention. In mmol/L, roughly under 0.9 reflects good metabolic health, and above 1.7 is where things start to look concerning.
A 2019 study in Diabetes & Metabolic Syndrome found that a high triglycerides HDL ratio was associated with insulin resistance markers in normal-weight adults, which is one of the reasons the ratio is useful. You can have a normal body mass index and still carry a worsening metabolic picture, and the ratio will often catch it.
These numbers are starting points, not targets. Someone eating a whole-food, low-carbohydrate diet may have different baseline markers than someone on a standard Western diet. Interpreting the numbers without dietary context can mislead.
What the ratio reflects about energy handling
Triglycerides and HDL are not independent readings. They are both downstream of how the body is handling energy. Triglycerides reflect how much excess energy the liver is processing. HDL reflects how effectively lipids are being transported and cleared. Put those together and you get a snapshot of metabolic state.
When the system is working, triglycerides tend to be lower and HDL tends to be higher. When the system is under pressure, triglycerides rise and HDL falls. That pattern is not random. It reflects how the liver, insulin, and overall energy handling are interacting.
A 1997 study in Circulation found that the triglycerides to HDL ratio was a strong predictor of myocardial infarction risk, adding cardiovascular relevance to a marker that is fundamentally a read on metabolism. If you have already read about fatty liver or the metabolic drivers behind stubborn belly fat, this is another way those same processes show up in your blood work.
Why this often says more than LDL alone
LDL is a transport particle. It carries information, but not enough on its own. Two people can present with the same LDL number and have completely different internal environments.
One has elevated triglycerides, low HDL, rising fasting glucose, and a liver under continuous load. The other has low triglycerides, higher HDL, stable blood sugar, and good insulin sensitivity. Same LDL on paper. Different system.
And LDL behaves differently in each. In a stressed system, LDL particles tend to remain in circulation longer, become smaller and denser, and are more susceptible to oxidative modification. In a stable system, that pattern is different. A 2013 review in Current Vascular Pharmacology described the shift toward small, dense LDL as a hallmark of insulin resistance. The number alone does not tell you enough. The context does. I have written about the wider cholesterol story and the dietary guidelines that still shape how most people think about fat and heart disease. There are also upstream factors that affect LDL oxidation and particle behaviour, including mineral status and copper, which rarely gets discussed in a lipid context.
When high LDL does not predict plaque progression
Emerging coronary imaging research is starting to challenge how we think about LDL in metabolically healthy people. In some cohorts eating very-low-carbohydrate diets with substantially elevated LDL, the expected correlation between LDL levels and plaque progression has not held. A 2025 longitudinal analysis in JACC Advances of the KETO-CTA cohort found that in lean metabolically healthy adults on ketogenic diets with markedly elevated LDL and apolipoprotein B (ApoB), the strongest predictor of future plaque was the amount of plaque already present, not the LDL number itself.
This does not prove LDL is irrelevant, and these are small data sets that do not apply to every population. But the direction is consistent with the broader point: markers do not behave the same way in every metabolic context. When LDL is read in isolation without knowing whether the person is insulin resistant or metabolically healthy, you risk missing what is actually driving the process.
Why the liver ends up producing more triglycerides
By the time you see triglycerides and HDL on a blood test, the process has already happened. This is not a cholesterol problem first. It is an energy handling problem. And one of the more overlooked pieces is how the body deals with mixed fuels.
The body can run on fat or on glucose, but it does not run both equally at the same time. It prioritises. Under normal conditions between meals, when insulin is low, muscle primarily runs on fat. Fatty acids are released into circulation and used as fuel. As Ben Bikman puts it: "Muscles love using fat as a fuel." That is the baseline state.
The problem starts when that baseline gets overridden. Modern diets deliver fat and carbohydrates together, repeatedly, and often in excess. At the cellular level, fat and glucose compete for oxidation, in what is known as the Randle cycle. A 2009 review in the American Journal of Physiology — Endocrinology and Metabolism revisited the Randle cycle and described how fat and glucose continuously compete for substrate oxidation, with fat generally taking priority. The excess glucose gets redirected: stored as glycogen, converted into intermediates like lactate, and sent back to the liver. Now the liver has to deal with it again: reprocess, recycle, or convert it into fat. Layer in frequent meals, mixed macronutrients, and excess intake, and the system backs up. A 2005 study in the Journal of Clinical Investigation quantified this directly in non-alcoholic fatty liver disease (NAFLD), finding that de novo lipogenesis accounted for roughly 26 percent of liver triglycerides, five times the rate seen in healthy controls. The liver was manufacturing fat from carbohydrate at five times the normal rate. Triglycerides rise, not because the system is broken, but because it is compensating.
When insulin and glucagon get elevated at the same time
This is not only a fuel-competition problem. It is also a hormonal control problem.
Insulin stores energy. Glucagon mobilises it. When the two are balanced, the system adapts smoothly. When they are disrupted, both can end up elevated at the same time. A 2012 review in the Journal of Clinical Investigation argued for a glucagonocentric restructuring of diabetes, describing how in metabolic disease insulin and glucagon become co-elevated rather than reciprocally regulated. Now the body is trying to store energy and release energy in parallel, and the result is a metabolic bottleneck.
A 2016 review in The International Journal of Molecular Sciences described the relationship between NAFLD and insulin resistance as bidirectional: the fatty liver worsens insulin resistance, and insulin resistance drives more fat into the liver. The outcome is consistent. Triglycerides rise, HDL tends to fall, and visceral fat accumulates. That same insulin-driven mechanism also disrupts sex hormone balance, which is one reason fatty liver and changes in body fat distribution often appear together.
Why triglycerides and HDL do not always move in lockstep
Triglycerides and HDL are often presented as moving in opposite directions, and in many cases they do. But the relationship is not fixed. It reflects what the system is doing underneath.
Triglycerides respond quickly to changes in liver energy handling. HDL reflects a slower, wider process: lipid transport, signalling, and turnover. In a metabolically stressed state, typically high insulin, frequent feeding, processed foods, and mixed high fat and high carbohydrate intake, triglycerides rise and HDL falls. In a more stable state, triglycerides fall and HDL often rises. But not always at the same speed. HDL can lag, and it can also be influenced by genetics, inflammation, hormonal state, and overall lipid turnover. So while the two markers often move in opposite directions, they are not mechanically tied. They are both responding to the same system, just differently.
Where LDL and apolipoprotein B still fit
The ratio does not replace LDL or ApoB. That would be overcorrecting in the other direction.
LDL and ApoB are relevant, particularly in terms of cumulative arterial exposure over time. A 2017 consensus statement in the European Heart Journal concluded that the causal role of LDL particles in atherosclerosis is supported by genetic, epidemiological, and clinical trial evidence. ApoB gives a closer count of those particles than standard LDL cholesterol does, which is why some researchers consider it the more useful lipid marker.
Where I diverge from the conventional framing is in how LDL is interpreted. Elevated LDL in someone who is metabolically unhealthy, with high triglycerides, low HDL, and insulin resistance, is a different situation from elevated LDL in someone eating a whole-food diet with strong metabolic markers. The triglycerides to HDL ratio tells you about the metabolic environment. LDL and ApoB add information about long-term particle exposure. You need both to read the picture properly.
Why the ratio gets worse in the first place
The factors that push the triglycerides HDL ratio in the wrong direction are the same ones that drive most metabolic problems, and they rarely come from a single source.
Refined carbohydrates and added sugar are the primary drivers. They push the liver into converting more glucose and fructose into fat, which raises triglycerides directly. Frequent eating, particularly snacking between meals, keeps insulin elevated throughout the day and never lets the system clear. Ultra-processed food compounds the effect. Excess alcohol raises triglycerides independently and adds to the load on the liver. Inactivity reduces the body's ability to use circulating fuel, so more of it stays in storage.
Sleep and stress belong on the same list. A 2022 systematic review in Sleep Medicine Reviews found that even short-term sleep restriction impairs glucose handling, and in my experience poor sleep is one of the most overlooked contributors to worsening metabolic markers. Chronic stress layers on top of that. None of these factors work in isolation; they accumulate, and the ratio reflects total metabolic load, not just diet.
What tends to improve it in practice
Improvement is not complicated: reduce the load and the ratio improves. I have seen this consistently, both in my own markers and in the people I work with.
Eating whole food and reducing refined carbohydrates is the biggest lever. A 2013 meta-analysis in the British Journal of Nutrition examined very-low-carbohydrate ketogenic diets versus low-fat diets and found that the ketogenic diets produced greater improvements in triglycerides alongside improved blood glucose and insulin regulation. You do not have to go ketogenic. In my case, cutting refined carbohydrates and building meals around whole food, animal protein, and natural fats brought my triglycerides down and HDL up within months. The ratio followed.
Activity helps. Sleep helps. Creating gaps between meals so insulin can drop helps. These are the same foundations I keep coming back to. I have written about what foundational health actually means and why the base has to be in place first.
If the ratio has been elevated for a long time, the shift is not instant. Most people see triglycerides start to move within four to six weeks of consistent dietary change. HDL tends to take longer, sometimes months. But the direction becomes clear early.
When the ratio can mislead or needs extra context
The ratio is useful, but it has limits. It does not replace LDL, ApoB, or clinical context. It tells you about the metabolic environment, not the full risk picture.
In people eating a very-low-carbohydrate or high-fat diet, the ratio can look excellent while LDL rises significantly. A 2024 meta-analysis in The American Journal of Clinical Nutrition found that low-carbohydrate diets raised LDL substantially in normal-weight adults but not in those with higher BMI. In the context of strong metabolic health, elevated LDL may not carry the same implications it would in someone with insulin resistance and a stressed liver, but it does not mean elevated LDL can be ignored entirely. Cumulative arterial exposure builds over decades.
Medications also shift the numbers in ways that can confuse the picture. Statins lower LDL without changing metabolic health, while fibrates and fish oil lower triglycerides. A medicated lipid panel does not tell you the same thing as an unmedicated one. Genetic lipid conditions like familial hypercholesterolaemia change the picture entirely. These are not driven by diet or metabolic health and need different interpretation.
One marker is never the full story. The triglycerides to HDL ratio sits alongside blood sugar markers, body composition, dietary context, and the rest of the clinical picture.
Reading the ratio as a pattern, not a target
The triglycerides to HDL ratio is not a target, it is a read on how the system is running. When it is favourable, the system is usually working. When it is not, something upstream is off. Treated as an isolated number, it is easy to misread. Once you understand what drives it (liver function, insulin, overall energy handling) it becomes one of the more useful markers on a standard lipid panel.
